Loading... Please wait...

Healthcare Research Review

Image 1
Price:
CAD $899.56
ISBN/SKU #:
GB-HLC068A
Research Group:
BCC
Date of Publication:
June 2009
Select License:
Bookmark and Share

Summary

Despite the global economic slowdown that began in 2008 and continues into 2009, technology markets in healthcare and related industries remain strong. Companies that provide technology products or related services to healthcare markets are well-positioned to weather the current weak economy and be poised to take full advantage of these growing markets when recovery arrives.
 
This report has provided comprehensive coverage of healthcare technology markets for many years, and we are now in the process of increasing our production of healthcare-related technology market research reports. This review of healthcare research conducted in 2008 and the first half of 2009 is meant to provide a sampling of the type of quantitative market information, analysis, and guidance that has been aiding business decision-making since was founded in 1971.
 
This review includes highlights of reports published the following healthcare technology markets:

  • Medical Diagnostic Kits
  • Minimally Invasive Medical Devices
  • Cancer Therapies
  • The Dental Market
  • Organ and Tissue Transplantation and Alternatives
  • Disabled and Elderly Assistive Technologies
  • Medical Device Coatings
  • Pediatric Health Care Products and Services

This study, Medical Diagnostic Kits (MDKs), provides the reader with an intensive examination of the in vitro medical diagnostic kit segment of the medical device market. It will specifically address the changes that have occurred as the result of technological advances and regulatory implementations from 2002 to 2007, and the impact these changes will have on the overall market and key market segments.

Beyond focusing on these changes, this report will define the entire MDK industry, including its structure and dynamics. The report will also discuss the major players, their relative market shares, the impact of external market forces, and implications for current and emerging technologies.

Significant changes have occurred in the MDK market in 2002. The market for analytical test kits packaged for use on a single-test basis to test for a wide variety of substances has been affected by dramatic changes in the global environment, as well as changes in demographics and national security issues within the United States.

Significant changes include the following:

  • An extremely large aging population of 78 million so-called “Baby Boomers”
  • Increasing rates of various types of cancer
  • Continued threat of bioterrorism through chemical/biological methods
  • An ever-increasing at-risk population of individuals with diabetes, hepatitis, and human papillomavirus
  • A slow down in HIV/AIDS diagnosed cases
  • A virtual epidemic of substance abuse
  • Introduction of infectious diseases from global migrations of people
  • Re-introduction of infectious diseases such as syphilis, tuberculosis, and measles, thought to be vanquished.

This report will identify and examine these marketplace trends and forecast future market changes from 2008 through 2013. The current marketplace is highly competitive among established companies and new entrants expanding the variety of tests available as MDKs. To differentiate their products from competitors, new technologies and innovative marketing strategies are being used. In addition to the expansion of the market through new tests, the MDK market is also affected by the development of inexpensive, automated testing devices, known as point-of-care (POC) instruments, which have replaced MDKs in smaller laboratories and physicians’ offices. This trend is definitely present in the clinical testing and veterinary markets. Additionally, clinical testing is being affected by the introduction of automated suites of instruments designed to increase the processing of diagnostic assay kits. All of the major manufacturers of MDKs now have automated suites of instrumentation for the clinical, research, and veterinary markets.

This study of the competitive and evolving MDK industry will be beneficial to diagnostic industry participants holding marketing, management, and technical development positions. It will also benefit readers who are suppliers to this industry. Additionally, investors, venture capitalists, insurance companies, and those interested in diagnostic medical testing will find this report valuable.
 
All products classified as MDKs are found in this report. These include products prepackaged for in vitro manual testing (whether the end point is detected by the naked eye or by using a reading device). The report specifically excludes tests that involve automated testing or tests that require processing devices and semi-automated batch testing devices.
 
The MDK market encapsulates current and potential products, related technologies, components and component suppliers, end markets, governmental and regulatory agencies, major companies competing in this market, relative market shares, and the impact of the worldwide market status.
 
This study defines the MDK market and provides detailed information on the following:

  • Products that comprise the MDK industry
  • Emerging and current MDK technologies
  • Analysis of these technologies and their effect on future products and market growth
  • Market structure and current market size, with forecasts through 2013, by each segment
  • Current market dynamics and trends
  • Emerging marketing practices, such as strategic alliances and acquisitions
  • The effect of external market forces, such as insurance, regulatory and economic issues, and increased incidence of disease
  • Internal aspects of the industry
  • Specific opportunities for industry participants and industry suppliers


TABLE OF CONTENTS

Chapter-1: MEDICAL DIAGNOSTICS KITS

INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED REPORTS
BCC ONLINE SERVICES
DISCLAIMER
SUMMARY
REPORT HIGHLIGHTS
TABLE 1 PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, THROUGH 2013 ($ MILLIONS)
FIGURE 1 PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, 2007–2013 ($ MILLIONS)
THE MDK INDUSTRY
WHAT ARE MDKS?
ADVANTAGES OF MDKS
USES FOR MDKS
Clinical Testing
Clinical Diagnostic Testing
Monitoring
Screening
Confirmatory Testing
Research
Home Use
Veterinary Diagnosis
MARKET SIZE
TABLE 2 PROJECTED U.S. MDK MARKET COMPARED WITH THE TOTAL DIAGNOSTIC TESTING INDUSTRY, THROUGH 2013 ($ BILLIONS)
Relation to Total Testing Market
FIGURE 2 MDK’S RELATIVE SHARE OF U.S. TESTING MARKET PROJECTED, THROUGH 2013 ($ BILLIONS)
ALTERNATIVE METHODS
TABLE 3 ALTERNATIVE METHODS TO MDKS AND AREA OF PRIMARY USE
Chemical Assay
Culture
Microscopy
Biological Assay
Chromatographic Separation
MDK APPLICATIONS
TABLE 4 SELECTED MDK APPLICATIONS
INDUSTRY STRUCTURE
Reagents
Device/Carrier
Packaging
Component Suppliers
FIGURE 3 COMPONENTS OF AN MDK
TABLE 5 SELECTED LISTING OF MDK COMPONENT SUPPLIERS BY AREA OF PARTICIPATION
END MARKETS
TABLE 6 MDK APPLICATIONS BY END-USE FACILITY
Clinical Testing Facilities
TABLE 7 U.S. CLINICAL TESTING FACILITIES WITH POTENTIAL FOR USING MDKS: CLIA VS. NON-CLIA
CLIA-Certified Laboratories
Non-CLIA Laboratories/Facilities
Research Laboratories
Home-Use Market
Veterinary Applications
TABLE 8 SELECTED LISTING OF ANIMAL TESTING MDKS
TRADE PRACTICES
Promotion
Pricing
Sales Tie-ins

Chapter-2: THE MARKET FOR MINIMALLY INVASIVE MEDICAL DEVICES

INTRODUCTION
MINIMALLY INVASIVE SURGERY
Minimally Invasive vs. Ambulatory Surgery
Minimally Invasive vs. Noninvasive Surgery
STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC RESEARCH STUDIES
SUMMARY
TABLE 9 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2014 ($ BILLIONS)
FIGURE 4 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2007–2014 ($ BILLIONS)
GEOGRAPHIC SEGMENTS
TABLE 10 MARKET FOR MIS DEVICES AND EQUIPMENT SALES BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 5 MAJOR MIS GEOGRAPHIC SEGMENTS, 2007 VS. 2014 (% OF TOTAL SALES)
END-USER SEGMENTS
TABLE11 U.S. MARKETS FOR MIS DEVICES AND EQUIPMENT SALES BY END-USER TYPE, THROUGH 2014 ($ MILLIONS)
FIGURE 6 MAJOR U.S. MIS END-USER SEGMENTS, 2007 VS 2014 (% OF TOTAL SALES)

Chapter-3: CANCER THERAPIES: TECHNOLOGIES AND GLOBAL MARKETS

INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC REPORTS
SUMMARY
TABLE 12 THE GLOBAL CANCER THERAPY MARKET, THROUGH 2013 ($ MILLIONS)
FIGURE 7 THE GLOBAL CANCER THERAPY MARKET, 2006–2013 ($ MILLIONS)
REGULATORY ISSUES
NEW DRUG APPROVALS
TABLE 13 CANCER DRUGS APPROVED BY THE FDA
NEW DRUG APPLICATIONS
TABLE 14 NEW DRUG APPLICATIONS (2005 TO JANUARY 2008)
RECALLS
TABLE 15 RECALLS (2005 TO JANUARY 2008)

Chapter-4: THE DENTAL MARKET: TECHNIQUES, EQUIPMENT, AND MATERIALS

INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
METHODOLOGY
RELATED BCC STUDIES
ANALYST CREDENTIALS
SUMMARY
THE DENTAL MARKET: MAJOR MARKETS SUMMARY
TABLE 16 TOTAL U.S. DENTAL MARKET ANALYSIS BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)
FIGURE 8 TOTAL U.S. DENTAL MARKET ANALYSIS BY PRODUCT SEGMENT, 2006–2013 ($ MILLIONS)
INDUSTRY OVERVIEW
STRUCTURE AND HISTORY OF THE DENTAL INDUSTRY
DESCRIPTIONS AND STATISTICS OF DENTAL PRACTICES
Endodontics
Orthodontics
Periodontics
Prosthodontics
Dental Offices
TABLE 17 DENTAL PROFESSIONALS BY YEAR, 1990–2005 (NUMBER)
Dental Laboratories
TECHNOLOGY
FUTURE OF DENTISTRY
DIGITAL INTRAORAL CAMERAS
REMINERALIZING AGENTS, FLUORIDE, AND BLEACHING PRODUCTS
PRACTICE MANAGEMENT SOFTWARE
DIGITAL AND 3D DIGITAL RADIOGRAPHY
SNAP-ON SMILE
LIGHT-ACTIVATED WHITENING SYSTEMS
AIR ABRASION
MINIMALLY INVASIVE TECHNIQUES
LASER CARIES DETECTION
COMPUTER-AIDED DRAFTING/COMPUTER AIDED MANUFACTURING (CAD/CAM)
PROFESSIONAL DENTAL EQUIPMENT AND SUPPLIES
OVERVIEW
DENTAL EQUIPMENT
Overview
Product Description
Dental Furniture
Operatory Units
TABLE 18 SELECTED MANUFACTURER AND DISTRIBUTOR LIST FOR GENERAL DENTAL FURNITURE
Cavity Preparation Systems and Air Abrasion Units
Dental Lasers
•Diode Laser
•CO2 Laser
•Erbium Laser
TABLE 19 SELECTED LIST OF DENTAL LASER MANUFACTURERS AND SUPPLIERS
Sterilizers and Autoclaves
TABLE 20 SELECTED DENTAL STERILIZER AND AUTOCLAVE SUPPLIERS
Amalgamators and Mixers
TABLE 21 SELECTED MANUFACTURERS AND DISTRIBUTORS OF AMALGAMATORS AND MIXERS
X-ray Devices and Related Equipment
•Digital Dental X-Ray Systems
•Film Processors
TABLE 22 SELECTED MANUFACTURERS AND DISTRIBUTORS OF DENTAL X-RAY DEVICES AND EQUIPMENT
Other Types of Dental Equipment
•Intraoral Cameras
TABLE 23 SELECTED MANUFACTURERS AND DISTRIBUTORS OF INTRAORAL CAMERAS
•Air Compressors and Vacuum Systems
TABLE 24 SELECTED MANUFACTURERS AND DISTRIBUTORS OF AIR COMPRESSORS AND VACUUM SYSTEMS
Nitrous Oxide Systems
TABLE 25 SELECTED MANUFACTURERS AND DISTRIBUTORS OF NITROUS OXIDE SYSTEMS
•Ultrasonic Cleaners
TABLE 26 SELECTED MANUFACTURERS AND DISTRIBUTORS OF ULTRASONIC CLEANERS
•Scalers
TABLE 27 SELECTED MANUFACTURERS AND DISTRIBUTORS OF DENTAL SCALERS
•Curing Lights
TABLE 28 SELECTED MANUFACTURERS AND DISTRIBUTORS OF CURING LIGHTS
•Laboratory Equipment
TABLE 29 SELECTED MANUFACTURERS AND DISTRIBUTORS OF LABORATORY EQUIPMENT
MARKET ANALYSIS
TABLE 30   MARKET FOR DENTAL EQUIPMENT BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)
FIGURE 9 MARKET FOR DENTAL EQUIPMENT BY PRODUCT SEGMENT, 2006–2013 ($ MILLIONS)

Chapter-5: ORGAN AND TISSUE TRANSPLANTATION AND ALTERNATIVES

INTRODUCTION
STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
AUTHOR’S CREDENTIALS
RELATED BCC PUBLICATIONS
SUMMARY
TABLE 31 U.S. MARKET FOR SOLID ORGAN AND TISSUE TRANSPLANTATION, THROUGH 2013 ($ MILLIONS)
FIGURE 10 U.S. MARKET FOR SOLID ORGAN AND TISSUE TRANSPLANTATION, 2007–2013 ($ MILLIONS)
INDUSTRY OVERVIEW
HISTORY OF TRANSPLANTATION
TISSUE TYPING
IMMUNOSUPPRESSION
Newer Immunosuppressive Drugs
PRESERVATION
GOVERNMENT REIMBURSEMENT
THE TRANSPLANTATION PROCESS
PREPARATION
SURGERY
RECUPERATION
MAINTENANCE
IMPORTANCE OF THE INDUSTRY
ORGANS
TABLE 32 U.S. ORGAN TRANSPLANTS: AVERAGE FIRST YEAR COST, NUMBER OF PROCEDURES AND VALUE BY TYPE OF ORGAN TRANSPLANT, THROUGH 2013 ($ MILLIONS)
KIDNEY
TABLE 33 LEADING U.S. KIDNEY TRANSPLANT PROGRAMS BY TOTAL NUMBER OF PROCEDURES PERFORMED IN 2007
LIVER
TABLE 34 TOP FIVE U.S. LIVER TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN 2007
HEART
TABLE 35 TOP FIVE U.S. HEART TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN 2007
LUNG
TABLE 36 TOP FIVE U.S. LUNG TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN 2007
INTESTINE
TABLE 37 TOP FIVE U.S. INTESTINE/SMALL BOWEL TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN 2007
PANCREAS
TABLE 38 TOP FIVE U.S. PANCREAS TRANSPLANT PROGRAMS BY TOTAL PROCEDURES PERFORMED IN 2007
TISSUES
DRIVERS IN THE MARKET
TABLE 39 TISSUE GRAFTING IN THE U.S. BY TISSUE TYPE, THROUGH 2013 (MILLION PROCEDURES)
FIGURE 11 U.S. MARKET FOR TISSUE GRAFTING PROCEDURES BY TYPE, 2007–2013 (MILLION PROCEDURES)
CORNEA
BLOOD STEM CELLS
BONE ALLOGRAFTS
HEART VALVES
VASCULAR TISSUE
SKIN AND COLLAGEN
Applications
WAITING LISTS OUTPACE DONATIONS
TABLE 40 PATIENTS ON U.S. WAITING LISTS AT THE END OF THE YEAR BY TYPE OF ORGAN TRANSPLANT, 2003–2006
TRENDS IN U.S. LIVING AND CADAVERIC DONATIONS
TABLE 41 TRENDS IN U.S. LIVING AND CADAVERIC DONATIONS, THROUGH 2013
TRENDS IN TRANSPLANTATION OF ALL ORGANS
TABLE 42 U.S. ORGAN TRANSPLANTS, THROUGH 2006 (NUMBER OF PROCEDURES)
INTERNATIONAL TRENDS
TABLE 43 NUMBERS OF DONATED CADAVERS BY REGION, 2003–2006
LIMITED SUPPLY CURTAILS TRANSPLANTATIONS
Living Donor Programs
KEY FACTORS IN INDUSTRY GROWTH
Reducing Demand
Patient Survival Rates
TABLE 44 ONE-YEAR AND FIVE-YEAR PATIENT SURVIVAL RATES, BY ORGAN FOR TRANSPLANTS PERFORMED, 1997–2004 (%)
TABLE 45 ONE-YEAR AND FIVE-YEAR GRAFT SURVIVAL RATES, BY ORGAN FOR TRANSPLANTS PERFORMED, 1997–2004 (%)
TABLE 46 NUMBER OF PEOPLE IN THE U.S. LIVING WITH A FUNCTIONING TRANSPLANT BY TYPE, 2000–2005*
Organ Substitutes
Organs from Animals: Xenotransplantation
Organ Primordia
Nuclear Transfer to Eliminate the Rejection Gene
Porcine Endogenous Retrovirus
ARTIFICIAL ORGANS
CELLULAR TRANSPLANTS
ORGAN REJECTION STRATEGIES
KEY FACTORS INHIBITING GROWTH
LACK OF DONORS
ALTERNATIVE THERAPIES
CULTURAL STIGMAS

Chapter-6: DISABLED AND ELDERLY ASSISTIVE TECHNOLOGIES IN THE U.S.

INTRODUCTION
ASSISTIVE TECHNOLOGY PRODUCTS
STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC RESEARCH REPORTS
SUMMARY
TABLE 47 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, THROUGH 2013 ($ MILLIONS)
FIGURE 12 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, 2007–2013 ($ MILLIONS)
INDUSTRY STRUCTURE AND COMPETITION
NUMBER AND SIZE OF FIRMS
MARKET SHARES
Mobility Aids
FIGURE 13 MOBILITY AIDS MARKET LEADERS, 2007 (%)
Access Aids
FIGURE 14 ACCESS AIDS MARKET LEADERS, 2007 (%)
Beds, Seating Systems, and Ergonomic Aids
FIGURE 15 BEDS, SEATING SYSTEMS, AND ERGONOMETRIC AIDS MARKET LEADERS, 2007 (%)
Daily Living Aids
FIGURE 16 DAILY LIVING AIDS MARKET LEADERS, 2007 (%)
Communication Aids
FIGURE 17 COMMUNICATION AIDS MARKET LEADERS, 2007 (%)
Computer Access Aids
FIGURE 18 COMPUTER ACCESS AIDS MARKET LEADERS, 2007 (%)
Vision and Reading Aids
FIGURE 19 VISION AND READING AIDS MARKET LEADERS, 2007
Environmental Aids
Medical/Personal Monitoring Aids
FIGURE 20 MEDICAL/PERSONAL MONITORING AIDS MARKET LEADERS, 2007 (%)

Chapter-7: MEDICAL DEVICE COATINGS

INTRODUCTION
STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
TWENTY-TWO MEDICAL SPECIALTIES
METHODOLOGY
INFORMATION SOURCES
ANALYST’S CREDENTIALS
RELATED BCC WORK CREDENTIALS
SUMMARY
TABLE 48 GLOBAL MEDICAL DEVICE COATING MARKET BY REGION, THROUGH 2014 ($ MILLIONS)
FIGURE 21 GLOBAL MEDICAL DEVICE COATING MARKET BY REGION, 2009 AND 2014 ($ MILLIONS)

Chapter-8: PEDIATRIC HEALTH CARE PRODUCTS AND SERVICES

INTRODUCTION
STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
INFORMATION SOURCES
ANALYST’S CREDENTIALS
RELATED BCC PUBLICATIONS
SUMMARY
PROJECTED GROWTH OF PEDIATRIC MARKETS
TABLE 49 GLOBAL TRENDS IN PEDIATRIC HEALTH CARE, THROUGH 2013 ($ MILLIONS)
FIGURE 22 GLOBAL TRENDS IN PEDIATRIC HEALTH CARE BASED ON CONDITION, 2007–2013 ($ MILLIONS)
MARKET FORECASTS FOR SHORT-TERM ILLNESSES
Rotavirus
Ear Infections
Upper Respiratory Infections
MARKET FORECASTS FOR CHRONIC ILLNESSES
Allergies
Attention Deficit Disorders
Asthma
Autism Spectrum Disorders
Diabetes
Obesity
OVERVIEW OF THE PEDIATRIC HEALTHCARE INDUSTRY
TABLE 50 PROJECTED PEDIATRIC PREVENTATIVE CARE COSTS FROM BIRTH THROUGH AGE 18 IN THE U.S., THROUGH 2013 ($ MILLIONS)
PRENATAL CARE/IMPLICATIONS
International Prenatal Care/Implications
Low Birth Weight
NEWBORN CARE
Care in the U.S.
International Newborn Care
Malnutrition
CHILDREN AGE 1 TO 6
CHILDREN AGE 7 TO 12
ADOLESCENT CHILDREN AGE 13 TO 18
ADOLESCENT REPRODUCTIVE HEALTH
Sexually Transmitted Diseases
Human Papillomavirus (HPV)
VACCINES/IMMUNIZATIONS
TABLE 51 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS
TABLE 52 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS
TABLE 53 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18
Vaccine Efficacy and Controversy
IMPLICATIONS FOR FUTURE DEVELOPMENTS IN THE U.S.
SHORT-TERM ILLNESSES IN THE PEDIATRIC POPULATION
TABLE 54 GLOBAL COSTS OF THREE PRIMARY SHORT-TERM ILLNESSES IN PEDIATRIC POPULATION, THROUGH 2013 ($ MILLIONS)
FIGURE 23 GLOBAL COST OF PEDIATRIC SHORT-TERM ILLNESS, 2008 AND 2013 ($ MILLIONS)
OTITIS MEDIA (EAR INFECTIONS)
Causes of Otitis Media
Allergies
Infection
Blockage
Nutrition and Breastfeeding
Types and Symptoms
Treatment
Pharmacological Intervention
•Use of Prevnar
TABLE 55 GLOBAL PRESCRIPTION COSTS FOR TREATMENT OF PEDIATRIC OTITIS MEDIA, THROUGH 2013 ($ MILLIONS)
TABLE 56 PRESCRIPTION COSTS FOR TREATMENT OF PEDIATRIC OTITIS MEDIA, IN THE U.S., THROUGH 2013 ($ MILLIONS)
Surgical Intervention
•Myringotomy
TABLE 57 GLOBAL SURGICAL COSTS FOR MYRINGOTOMY IN PEDIATRIC PATIENTS, THROUGH 2013 ($ MILLIONS)
TABLE 58 SURGICAL COSTS FOR MYRINGOTOMY IN U.S. PEDIATRIC PATIENTS, THROUGH 2013 ($ MILLIONS)
•Adenoidectomy and Tonsillectomy
TABLE 59 GLOBAL SURGICAL COSTS FOR TONSILLECTOMY/ADENOIDECTOMY IN PEDIATRIC PATIENTS, THROUGH 2013 ($ MILLIONS)
TABLE 60 SURGICAL COSTS FOR TONSILLECTOMY/ADENOIDECTOMY IN U.S. PEDIATRIC PATIENTS, THROUGH 2013 ($ MILLIONS)
GASTROINTESTINAL ILLNESSES
Rotavirus
Transmission
Symptoms
Treatment
•Dehydration
•Zinc
Vaccinations
•Rotateq
•Rotarix
TABLE 61 GLOBAL VACCINATION FOR PEDIATRIC ROTOVIRUS, THROUGH 2013 ($ MILLIONS)
TABLE 62 U.S. VACCINATION FOR PEDIATRIC ROTOVIRUS, THROUGH 2013 ($ MILLIONS)
Gastroesophageal Reflux
Treatment
•Eliminate Symptoms
•Heal Esophagus
•Prevent Complications
TABLE 63 CURRENT TREATMENTS FOR GERD
UPPER RESPIRATORY INFECTIONS
TABLE 64 GLOBAL DIRECT COSTS OF PEDIATRIC UPPER RESPIRATORY INFECTIONS, THROUGH 2013 ($ MILLIONS)
TABLE 65 DIRECT COSTS FOR PEDIATRIC UPPER RESPIRATORY INFECTIONS IN THE U.S, THROUGH 2013 ($ MILLIONS)
Causes and Symptoms
TABLE 66 COMMON SYMPTOMS OF AN URI
Treatments
Increased Fluid Intake
Second-Hand Smoke
Medications
Antibiotic Treatments
Withdrawing Medicines
Complications

 

 

Additional Information

Number of Pages: 174

Find Similar Products by Category

Currency Converter

Choose a currency below to display product prices in the selected currency.

United States US Dollars
Canada Canadian Dollars

Add to Wish List

Click the button below to add the Healthcare Research Review to your wish list.